Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

Response to letter regarding article, "Granulocyte colony-stimulating factor in patients with acute ischemic stroke: results of the AX200 for Ischemic Stroke Trial".

Schneider A, Schäbitz WR, Ringelstein EB.

Stroke. 2014 Jan;45(1):e9. doi: 10.1161/STROKEAHA.113.003833. No abstract available.

2.

Letter by Taguchi et al regarding article, "Granulocyte colony-stimulating factor in patients with acute ischemic stroke: results of the AX200 for Ischemic Stroke Trial".

Taguchi A, Kasahara Y, Matsuyama T.

Stroke. 2014 Jan;45(1):e8. doi: 10.1161/STROKEAHA.113.003683. No abstract available.

3.

Granulocyte colony-stimulating factor enhances arteriogenesis and ameliorates cerebral damage in a mouse model of ischemic stroke.

Sugiyama Y, Yagita Y, Oyama N, Terasaki Y, Omura-Matsuoka E, Sasaki T, Kitagawa K.

Stroke. 2011 Mar;42(3):770-5. doi: 10.1161/STROKEAHA.110.597799.

4.

Phase I study of intravenous low-dose granulocyte colony-stimulating factor in acute and subacute ischemic stroke.

Moriya Y, Mizuma A, Uesugi T, Ohnuki Y, Nagata E, Takahashi W, Kobayashi H, Kawada H, Ando K, Takagi S, Takizawa S.

J Stroke Cerebrovasc Dis. 2013 Oct;22(7):1088-97. doi: 10.1016/j.jstrokecerebrovasdis.2012.08.002.

PMID:
22959110
5.

Granulocyte colony-stimulating factor for acute ischemic stroke: a randomized controlled trial.

Shyu WC, Lin SZ, Lee CC, Liu DD, Li H.

CMAJ. 2006 Mar 28;174(7):927-33.

6.

Granulocyte-colony stimulating factor (G-CSF) and G-CSF receptor expression in human ischemic stroke.

Hasselblatt M, Jeibmann A, Riesmeier B, Maintz D, Schäbitz WR.

Acta Neuropathol. 2007 Jan;113(1):45-51.

PMID:
17047971
7.

Impact of the neutrophil response to granulocyte colony-stimulating factor on the risk of hemorrhage when used in combination with tissue plasminogen activator during the acute phase of experimental stroke.

Gautier S, Ouk T, Tagzirt M, Lefebvre C, Laprais M, Pétrault O, Dupont A, Leys D, Bordet R.

J Neuroinflammation. 2014 May 27;11:96. doi: 10.1186/1742-2094-11-96.

8.

Endogenous granulocyte colony-stimulating factor: a biomarker in acute ischemic stroke.

Yu SC, Kuo CL, Huang CS, Chang CS, Wu SL, Su SL, Liu CS.

Biomarkers. 2012 Jun;17(4):319-24. doi: 10.3109/1354750X.2012.668712.

PMID:
22440005
9.

AXIS: a trial of intravenous granulocyte colony-stimulating factor in acute ischemic stroke.

Schäbitz WR, Laage R, Vogt G, Koch W, Kollmar R, Schwab S, Schneider D, Hamann GF, Rosenkranz M, Veltkamp R, Fiebach JB, Hacke W, Grotta JC, Fisher M, Schneider A.

Stroke. 2010 Nov;41(11):2545-51. doi: 10.1161/STROKEAHA.110.579508.

10.

Inhibited glutamate release by granulocyte-colony stimulating factor after experimental stroke.

Han JL, Blank T, Schwab S, Kollmar R.

Neurosci Lett. 2008 Feb 27;432(3):167-9. doi: 10.1016/j.neulet.2007.07.056. Erratum in: Neurosci Lett. 2009 Jan 16;449(3):258. Tobyas, Blank [corrected to Blank, Tobias].

PMID:
18255224
12.

Bone marrow cell transplantation time-dependently abolishes efficacy of granulocyte colony-stimulating factor after stroke in hypertensive rats.

Pösel C, Scheibe J, Kranz A, Bothe V, Quente E, Fröhlich W, Lange F, Schäbitz WR, Minnerup J, Boltze J, Wagner DC.

Stroke. 2014 Aug;45(8):2431-7. doi: 10.1161/STROKEAHA.113.004460.

13.

Colony stimulating factors (including erythropoietin, granulocyte colony stimulating factor and analogues) for stroke.

Bath PM, Sprigg N, England T.

Cochrane Database Syst Rev. 2013 Jun 24;(6):CD005207. doi: 10.1002/14651858.CD005207.pub4. Review.

PMID:
23797623
14.

Allometric dose retranslation unveiled substantial immunological side effects of granulocyte colony-stimulating factor after stroke.

Wagner DC, Pösel C, Schulz I, Schicht G, Boltze J, Lange F, Scheibe J, Möller K, Weise G.

Stroke. 2014 Feb;45(2):623-6. doi: 10.1161/STROKEAHA.113.003812.

15.

The role of stem cell factor and granulocyte-colony stimulating factor in treatment of stroke.

Zhao LR, Piao CS, Murikinati SR, Gonzalez-Toledo ME.

Recent Pat CNS Drug Discov. 2013 Apr;8(1):2-12. Review.

16.

Letter regarding article by Shyu et al, "functional recovery of stroke rats induced by granulocyte colony-stimulating factor-stimulated stem cells".

Buschmann IR, Hossmann KA.

Circulation. 2005 May 17;111(19):e297-8; author reply e297-8. No abstract available.

18.

Granulocyte colony-stimulating factor does not promote neurogenesis after experimental intracerebral haemorrhage.

Kallmünzer B, Tauchi M, Schlachetzki JC, Machold K, Schmidt A, Winkler J, Schwab S, Kollmar R.

Int J Stroke. 2014 Aug;9(6):783-8. doi: 10.1111/ijs.12217.

PMID:
24920160
20.

A neuroprotective function for the hematopoietic protein granulocyte-macrophage colony stimulating factor (GM-CSF).

Schäbitz WR, Krüger C, Pitzer C, Weber D, Laage R, Gassler N, Aronowski J, Mier W, Kirsch F, Dittgen T, Bach A, Sommer C, Schneider A.

J Cereb Blood Flow Metab. 2008 Jan;28(1):29-43.

PMID:
17457367
Items per page

Supplemental Content

Support Center